ProShare Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-131,537
| Closed | -$224K | – | 1784 |
|
|
2018
Q3 | $224K | Sell |
131,537
-4,896
| -4% | -$8.34K | ﹤0.01% | 1530 |
|
|
2018
Q2 | $237K | Sell |
136,433
-9,398
| -6% | -$16.3K | ﹤0.01% | 1519 |
|
|
2018
Q1 | $267K | Sell |
145,831
-23,971
| -14% | -$43.9K | ﹤0.01% | 1386 |
|
|
2017
Q4 | $379K | Buy |
169,802
+27,511
| +19% | +$61.4K | ﹤0.01% | 1265 |
|
|
2017
Q3 | $413K | Buy |
142,291
+6,788
| +5% | +$19.7K | ﹤0.01% | 1037 |
|
|
2017
Q2 | $603K | Buy |
135,503
+5,405
| +4% | +$24.1K | 0.01% | 889 |
|
|
2017
Q1 | $606K | Sell |
130,098
-17,928
| -12% | -$83.5K | 0.01% | 944 |
|
|
2016
Q4 | $901K | Buy |
148,026
+16,916
| +13% | +$103K | 0.01% | 823 |
|
|
2016
Q3 | $722K | Sell |
131,110
-24,903
| -16% | -$137K | 0.01% | 795 |
|
|
2016
Q2 | $593K | Buy |
156,013
+59,611
| +62% | +$227K | 0.01% | 895 |
|
|
2016
Q1 | $266K | Sell |
96,402
-9,576
| -9% | -$26.4K | ﹤0.01% | 1264 |
|
|
2015
Q4 | $601K | Buy |
105,978
+10,655
| +11% | +$60.4K | 0.01% | 956 |
|
|
2015
Q3 | $505K | Buy |
95,323
+2,759
| +3% | +$14.6K | 0.01% | 937 |
|
|
2015
Q2 | $768K | Sell |
92,564
-3,373
| -4% | -$28K | 0.01% | 896 |
|
|
2015
Q1 | $443K | Buy |
95,937
+11,834
| +14% | +$54.6K | 0.01% | 1243 |
|
|
2014
Q4 | $257K | Sell |
84,103
-1,958
| -2% | -$5.98K | ﹤0.01% | 1621 |
|
|
2014
Q3 | $240K | Sell |
86,061
-16,487
| -16% | -$46K | ﹤0.01% | 1856 |
|
|
2014
Q2 | $417K | Sell |
102,548
-48,062
| -32% | -$195K | 0.01% | 1697 |
|
|
2014
Q1 | $800K | Buy |
150,610
+104,399
| +226% | +$555K | 0.01% | 1483 |
|
|
2013
Q4 | $257K | Sell |
46,211
-37,506
| -45% | -$209K | ﹤0.01% | 1206 |
|
|
2013
Q3 | $377K | Buy |
83,717
+31,959
| +62% | +$144K | 0.01% | 1711 |
|
|
2013
Q2 | $221K | Buy |
+51,758
| New | +$221K | ﹤0.01% | 1960 |
|